Moderate riskFDA DrugClass II

Hikma ramipril capsules recalled for failed impurity specification

Hikma Pharmaceuticals is recalling specific lots of Ramipril Capsules 10 mg because testing found higher-than-allowed levels of dicyclohexylurea, a process impurity. The affected lots are AC5470A and AC5470B, both expiring July 2027. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Hikma Pharmaceuticals recalls

What to do

  1. Check if your Ramipril prescription matches lot AC5470A or AC5470B with July 2027 expiration.
  2. Contact your pharmacy or doctor if you have one of these lots.
  3. Do not stop taking Ramipril without talking to your doctor first.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
a) 25,970 bottles; b) 2,384 bottles
Illnesses reported
None reported
Manufactured in
1809 Wilson Rd, N/A, Columbus, OH, United States
Classification
Class II
Recall number
D-0831-2026

In the FDA's words

Description
Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228. Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU). a) Lot #: AC5470A, Exp. Date July 2027 b) Lot #: AC5470B, Exp. Date July 2027 Distribution: Nationwide within the United States Affected quantity: a) 25,970 bottles; b) 2,384 bottles
Hazard
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).

More from Hikma Pharmaceuticals

See all

Related topics